Full List Of Stories
FTSE 100 movers: Astra and Glaxo provide shot in the arm
London's FTSE 100 index was up 0. 3% above 7,400 by mid afternoon on Friday and moving towards a potential record weekly thanks to a booster from drug developer AstraZeneca.
Petrofac under investigation by Serious Fraud Office, CEO questioned
The Serious Fraud Office has launched a criminal investigation into Petrofac, its subsidiaries and its employees, which the agency confirmed was over suspicions of bribery, corruption and money laundering.
Lloyds Banking hit by structured investments mis-selling scandal
Lloyds Banking Group shares were hit on Friday by reports that it may have to pay £80m to compensate customers in a fresh mis-selling scandal.
AstraZeneca surges on good news from lung cancer trial
AstraZeneca's durvalumab immuno-oncology drug has become the first such medicine to successfully treat advanced lung cancer patients who had not had success with chemotherapy.
Gfinity raises £6.25m to launch Elite Series e-sports competition
E-sports business Gfinity has secured a gross £6. 25m of new funds in a discounted and oversubscribed institutional placing on Friday, which knocked the shares down further from their recent two-year high.
BOS Global sells interest in once-exciting Olympic Dam mining asset
Australian productivity software developer BOS Global has agreed to sell its 75% legacy interest in a South Australia mining property to boss Michael Travia.
Interserve reports more settled trading
Interserve said trading so far in 2017 has been in line with forecasts, with progress being made on its troublesome exit from the energy-from-waste business.
Redefine signs up new Derby tenant for 50% rent boost
Redefine International has signed a 15-year lease with TK Maxx for a property in Derby for 50% above its estimated retail value as it spends £2. 2m on redeveloping the store space.